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ABSTRACT
Aim: To investigate the suitability of metabolic
equivalents (METs) for determining exercise intensity
in phase-IV post-myocardial infarction (MI) men during
the modified Bruce treadmill walking test (MBWT).
Methods: Twenty phase-IV post-MI men (meanSD,
aged 64.45.8 years) and 20 healthy non-cardiac male
controls (59.87.6 years) participated. Participants
performed a MBWT. Throughout the participants’ heart
rate (HR), heart rhythm, expired air parameters and
ratings of perceived exertion (RPEs) were measured.
MET values were compared between groups and those
currently ascribed to each stage of the MBWT.
Results: General linear model analysis found no
significant differences between groups during the
MBWT for VO2, VCO2, HR, METs or RPEs (Borg 6–20
scale). Ascribed METs did not differ from mean METs
of post-MIs or controls other than at stage 5 where
post-MI METs were significantly lower. Irrespective,
the post-MI group worked at a higher percentage of
their anaerobic threshold (AT) (respiratory exchange
ratio, RER=1.0) (F(2,5)=7.22, p<0.008), higher RER
(F(2,5)=11.25, p<0.001) with increased breathing
frequency (F(2,5)=7.22, p<0.001). Regression analysis
revealed AT to be VO2 25.6 (mL/kg/min) for post-MI
versus VO2 31.1 (mL/kg/min) for controls. Gross
energy expenditure (kcal/min) was greater for the post-
MI group compared with controls (F(2,5)=11.22,
p<0.001). Throughout the MBWT, post-MI group
worked at a higher %AT/MET than controls
(F(2,196)=211.76, p<0.01). Body composition did not
strongly influence %AT/MET, parameters of VO2, METs
or RPE.
Conclusion: During the MBWT, post-MI men worked
more anaerobically per MET (%AT/MET) than controls.
Therefore, current METs based on non-cardiac
individuals appear unsuitable in determining the full
metabolic load of the exercise intensity for cardiac
patients during the MBWT.
INTRODUCTION
The graded modified Bruce treadmill
walking test (MBWT) protocol1 is interna-
tionally employed in clinical situations to
determine the exercise intensity at which a
cardiac patient achieves their ischaemic
threshold.2–5 The MBWT results are also
frequently used to estimate a patient’s func-
tional capacity and risk stratification, and/or
to assist those in cardiac rehabilitation (CR)
in prescribing exercise of an appropriate
intensity. Each stage of the test is aligned
with a metabolic equivalent (MET), which is
a multiple of 1 MET, estimated to be
around 3.5 mL O2/kg/min of resting oxygen
uptake (VO2 mL/kg/min). METs were origi-
nally devised to allow easy prescription of
exercise and estimation of energy expendi-
ture of various physical activities for the
general public, and tables were produced
providing MET values over a range of activ-
ities.6 7 For most adults, the multiples of the
resting 1 MET value appear to be reason-
ably appropriate. However, over time there
has been increasing concern that METs are
being used too specifically and are unsuit-
able for use on certain populations,8–14 one
example being those with cardiac disease.11
12 Ainsworth et al,6 7 who devised the MET
tables, readily state that for extremely over-
weight and underweight individuals current
MET values may be inappropriate, and it
has been suggested that adjustments are
required for cardiac patients.15 Taking
What are the new findings?
" Phase-IV post-myocardial infarction (MI) men
work at a higher percentage of their anaerobic
threshold per metabolic equivalent (MET) than
non-cardiac individuals during the modified
Bruce treadmill walking test (MBWT).
" Current MET values underestimate the metabolic
load (exercise intensity) of phase-IV post-MI
men during the MBWT.
" The subjective term ‘slightly breathless, slightly
sweaty’ appears to be achieved at around 43% of
anaerobic threshold (RER=1.0) for both post-MI
men and non-cardiac controls.
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these issues into account, the primary aim of this
present study was to investigate whether current METs
were suitable for determining exercise intensity in
post-myocardial infarction (MI) men during the
MBWT when compared with non-cardiac controls, as
well as METs ascribed to each stage of the MBWT.
Secondary aims were to determine if body composition
was influential on the MET values achieved at each
MBWT stage and whether subjective markers of exer-
cise intensity were related to the MET values.
METHODS
All methods and processes were approved by the
NRES Committee South East Coast-Kent, REC refer-
ence: 12/LO/1663; IRAS Project No. 111944, and by
the Faculty of Social and Applied Sciences REC.
Power and sample size calculations
Based on a previously observed statistically significant
difference in METs of 0.650.51 between cardiac
patients and those with normal heart function during
exercise,16 using Minitab statistical package (V.17),
n=15 participants were required in each group to
achieve 90% power at an alpha of 0.05. Allowing for
potential attrition n=20 participants were recruited to
each group.
Participant recruitment
Twenty uncomplicated post-MI men (2.42.0 years
since MI) were recruited through community phase-IV
CR exercise classes. Twenty non-cardiac, apparently
healthy, male volunteers were recruited from the same
area through word of mouth and posters. All volun-
teers were given a Participant Information Sheet and
interested individuals were asked to complete a Health
and Physical Activity Screening Questionnaire. Post-MI
patients were required to be ‘uncomplicated,’ stable, at
phase-IV CR level, taking standard medications (such
as statin, beta-blocker, aspirin and ACE inhibitor).
Potential controls were to be free of cardiac disease
and/or event and/or chronic medical condition and/or
taking long-term medications. All participants were
required to be non-smoking, to understand the nature
of the study, to be between 50 and 75 years of age,
to perform similar levels of regular physical activity
and to be free from any orthopaedic limitations during
exercise. Participants who cleared screening were
required to provide written informed consent and
written acknowledgement of their participation from
their general practitioner (GP). Participants were free
to withdraw from the study at any time without
providing a reason.
Procedures
All data were collected in the same BASES Accredited
Exercise Laboratory and participants were familiarised
by visiting the laboratory, undergoing all testing
procedures not more than 10 days prior to actual data
collection. All participants were familiarised so that
during treadmill walking they could walk without
holding onto the handrail. Prior to each testing
session, each participant was asked pretest screening
questions to ensure they were sufficiently healthy and
had adhered to pretest criteria. This required partici-
pants to wear appropriate loose clothing, not to eat or
drink anything containing caffeine within 2 hours, nor
to consume alcohol or to exercise within 24 hours of
tests. Those on medications were asked to take these as
normal. On arrival, each participant was measured for
height (Stadiometer Seca 220, Hamburg, Germany)
and body mass (Seca 710), and body mass index (BMI)
was derived. Each participant then sat quietly for
10min while measures of resting blood pressure
(BP; mm Hg) (Yamasu Mercurial Spygmomanometer
605P, Kenzmedico, Japan), heart rate (HR; bpm) and
rhythm were recorded (12-lead ECG, Cosmed, Italy).
Each participant then lay supine for 10min for pre-
exercise measures of resting oxygen uptake (VO2),
which was not considered a measure of resting meta-
bolic rate. Expired air was collected via a face mask
covering the mouth and nose (Hans Rudolph Adult
Mask, 8930/8940 Series, Kansas, USA), analysed using
an online system (Cosmed Quark b2 Cardiopulmonary
Exercise Testing System, Rome, Italy). Information was
transmitted and recorded instantly. Each participant
was not permitted to proceed if any unexpected heart
abnormalities were detected and/or if their BP was
greater than 180mm Hg systolic and/or 100mm Hg
diastolic, or resting HR>100bpm.17 18 After clearing
screening and briefing, each participant signed
informed consent, after which they were measured for
body composition by whole-body air-displacement
plethysmography (Bod Pod, Cosmed Italy), which
required sitting in an enclosed capsule for around
5min wearing close fitting swimwear, after which the
participant put on suitable clothing to proceed with the
MBWT (table 1). Because phase-IV post-MI patients
have shown to cope with treadmill walking speeds of
3.8 mph at 0% gradient,11 12 for the purpose of this
study testing was terminated at stage 5 (14% gradient
at 3.4 mph). It was considered that too few post-MI
patients would complete any further stages, affecting
statistical significance, and therefore any unnecessary
physical stress was considered unethical. Throughout,
participants were monitored closely, expired air
(breath-by-breath), HR and rhythm as described previ-
ously. Average of final minute breath-by-breath MET
values were used in analysis. Subjective ratings of
perceived exertion (RPEs) Borg 6–20 scale19 were
taken during the final minute of each stage of the test.
As another potential subjective marker of intensity,
during the MBWT each participant was also requested
to indicate the point where they subjectively felt
‘slightly breathless and slightly sweaty.’
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The test was terminated at any point when the partic-
ipant no longer wished to continue, or if the
participant experienced or showed signs of undue
fatigue, displayed symptoms and produced measures
that indicated they had reached or exceeded their
exercise tolerance level. The researchers also termi-
nated the test if it was considered dangerous for the
participant to continue, for example, if the 12-lead
ECG detected changes in cardiac function (particularly
ST segment changes) indicative of myocardial
ischaemia. The alert was set to inform researchers
when ST segment depression of 1mm was detected.
This was not used diagnostically but for safety moni-
toring purposes only. However, any suspected
abnormalities were conveyed to the participant and
their GP for follow-up. Immediately after the MBWT,
the face mask was removed and the participant
performed 10min self-paced walking cooldown.
Following cooldown, the participant was seated and
HR and BP were re-checked, ensuring sufficient
recovery.20
Data analysis
Statistical analysis using Minitab statistical package
V.17 was employed. All measured variables were
checked for normal distribution of data. Statistical
difference was set at p<0.05 alpha level. An indepen-
dent samples t-test was employed to determine any
baseline differences between the groups and differ-
ences between groups at the various data points during
the MBWT for the measured variables. Analysis
comparing two lines of regression was employed to
determine the differences between the trajectories of
the various measured factors for the two groups. Pear-
son’s product–moment correlations were conducted to
determine any meaningful and significant relationships
between the measured factors. The general linear
model (GLM) analysis was used to determine
the statistical differences between the groups of the
various measured factors during the MBWT, with the
application of the ‘Bonferroni’ correction factor, which
changed the level of acceptable significance in
accordance with the number of data points being taken
into account.
All MET values were based on the standard 3.5mL
O2/kg/min. Respiratory exchange ratio (RER), VCO2/
VO2=1.0, was used to describe point of anaerobic
threshold (AT) as this has been deemed appropriate
when testing cardiac patients where HR values are
unreliable.21 The point of AT for each group was calcu-
lated using regression equations, post-MI group VO2
mL/kg/min=23.8+49.4 RER, and controls VO2 mL/kg/
min=-29.6+60.7 RER. During the MBWT, expired air
variables were measured, from which gross energy
expenditure and METs were calculated. Energy expen-
diture was determined using the established equation
of kcal/LO2/min=1.2411RER+3.8076, R
2=0.9996.22
All data were double-checked for transcript errors.
RESULTS
Participant characteristics
There were no statistically significant differences in
participant characteristics between the two groups,
other than body composition (table 2). Even though
the groups were similar in body mass, the post-MI
participants displayed a significantly greater BMI,
percentage body fat and kilograms of body fat, with a
lower percentage of lean body mass (LBM) (table 2).
Medications
All 20 post-MI patients were taking aspirin, a statin
and a beta-blocker, which were found to have no statis-
tically significant effect on any of the measured factors.
Post-MI patients were also taking a number of different
cardiovascular medications. However, the numbers
were too few to calculate any statistical effect on the
measured variables (table 3).
Modified Bruce treadmill walking test
Two post-MI participants were stopped during stage 5
of the MBWT, as one displayed an ST depression of
1.7mm and the other an RER of 1.11, also failing to
keep pace and showing increasedbreathlessness.
Table 1 Incremental stages for the MBWT protocol
Stage
Modified Bruce Full Bruce Speed (m/h) Grade (%) Duration (min) Ascribed METs1
1 – 1.7 0 3 1.7
2 – 1.7 5 3 2.9
3 1 1.7 10 3 4.7
4 2 2.5 12 3 7.1
5 3 3.4 14 3 10.2
MBWT, modified Bruce treadmill walking test; MET, metabolic equivalent.
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VO2 parameters and derived METs
The GLM analysis found no significant differences
between the non-cardiac controls and post-MI
group during the MBWT for oxygen uptake (VO2)
(mL/kg/min) or VO2 (l/min), amount of VCO2 (mL/kg/
min) or VCO2 (L/min), HR, METs or subjective RPEs
(table 4).
There were no significant differences in mean MET
values for the stages of the MBWT between the groups
or ascribed MET values. Though during stage 5, post-
MI participants’ MET values were significantly lower
(F(2,5)=8.45, p<0.006) (table 5).
Throughout the MBWT, post-MI participants worked
at a higher percentage of their AT (F(2,5)=7.22,
p<0.008), with increased breathing frequency (BF)
(breaths/min) (F(2,5)=7.22, p<0.001) and higher RER
(F(2,5)=11.25, p<0.001). Gross energy expenditure
(kcal/min) was found to be significantly greater for
post-MI participants compared with controls,
(F(2,5)=11.22, p<0.001) (table 4). AT was calculated to
be VO2 25.6 (mL/kg/min) for the post-MI versus
control 31.1(mL/kg/min). Calculations were also
performed to determine the percentage of AT that
each participants worked during the MBWT in relation
to their MET values (%AT/MET). This revealed that
during the MBWT, post-MI participants worked at a
significantly higher %AT/MET, (F(2,196)=211.76,
p<0.01) (figure 1).
Body composition
Analysis found no significant relationship between VO2
(mL/kg/min) or METs with body composition.
Table 2 Participant characteristics at baseline, meanSD (range)
Controls n=20
Mean±SD (range)
Post-MIs n=20
Mean±SD (range)
Age (years) 59.87.6 (51–73) 64.45.8 (54–75)
Height (m) 1.797.5 (1.57–1.94) 1.776.3 (1.66–1.90)
Body mass (kg) 80.810.8 (58.2–105.6) 84.023.9 (65.5–121.5)
BMI (kg/m2) 25.01.9 (20.7–28.1) 28.04.5 (21.7–37.9)*
% Body fat 22.86.4 (11.9–34.4) 28.96.9 (16.6–40.7)*
% LBM 77.56.3 (65.6–88.1)* 71.16.9 (59.3–83.4)
Body fat (kg) 18.7–6.4 (8.6–31.2) 26.1–10.4 (10.9–49.5)*
LBM (kg) 62.27.5 (47.2–76.2) 61.67.1 (48.5–73.6)
Pre-exercise resting measures
SBP (mm Hg) 137.312.5 (108–153) 135.014.7 (107–169)
DBP (mm Hg) 81.37.5 (70=95) 76.68.6 (62–88)
HR (bpm) 55.48.4 (54–76) 57.48.5 (55–73)
VO2 (mL/kg/min) 3.60.8 (2.7–5.5) 3.507 (2.5–4.8)
VO2 (L/min) 0.290.07 (0.16–0.49) 0.330.15 (0.21–0.92)
RPP (bpmSBP mm Hg) 76131477 (5805–11172) 78281670 (5029–11340)
Self-reported days per week of physical activity
30min sessions at moderate intensity 3.82.0 (0–7) 3.81.9 (0–7)
20min sessions at vigorous intensity 2.51.5 (0–5) 2.00.9 (0–4)
*Statistically significantly different at p<0.01 level.
Table 3 Number of cardiovascular medications taken by
post-MI patients
Medication
Number of post-
MI patients
Aspirin 19
Clopidogrel 4
Warfarin 1
Beta-blocker 20
Statin 20
ACE inhibitor 17
Angiotensin receptor
antagonist
2
Alpha-blocker 1
GTN 1
GTN, glyceryl trinitrate; MI, myocardial infarction.
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Table 4 Measured variables during and after MBWT (meanSD)
Stage Groups
HR
(bpm)
VO2
(L/min)
VO2
(mL/kg/
min)
VCO2
(L/min)
VCO2
(mL/kg/
min)
VE
(L/min) RER
Gross (kcal/
min)
Percentage
AT
BF
(breath/
min) RPE
1 Controls 70.210.4 0.780.16 9.71.6 0.560.13 7.02.0 22.05.9 0.710.05 4.70.06 31.35.8 16.44.3 6.90.5
Post-MIs 72.88.9 0.910.17* 10.41.6 0.640.19 8.03.0 24.55.5 0.730.04 4.70.06 40.86.1** 21.81.0** 7.41.3*
2 Controls 77.010.4 0.990.14 12.31.3 0.720.12 9.02.0 25.95.2 0.730.05 4.70.06 39.54.1 16.24.2 8.81.1
Post-MIs 80.710.9 1.110.13** 12.81.9 0.830.21 10.03.0** 30.75.2** 0.780.06** 4.80.08** 50.27.2** 21.25.10** 8.91.4
3 Controls 87.116.0 1.260.19 15.61.8 0.980.16 13.02.0 35.18.5 0.780.06 4.80.01 50.25.8 17.44.6 10.81.2
Post-MIs 89.811.3 1.430.19* 16.52.3 1.140.29* 14.04.0** 40.68.2* 0.840.05** 4.90.06** 64.38.8** 24.77.0** 11.12.3
4 Controls 107.013.6 1.850.28 23.02.9 1.500.22 19.03.0 51.110.8 0.820.07 4.80.09 74.09.4 19.64.4 12.81.6
Post-MIs 110.412.3 1.950.28 22.52.4 1.660.49 20.06.0 58.711.6* 0.890.06** 4.90.07** 87.89.3** 28.44.0 13.21.3
5 Controls 136.712.9 2.640.43 32.63.0 2.470.35 31.05.0 74.211.3 0.940.09 5.00.11 104.99.7 25.34.2 15.31.4
Post-MIs
n=18
132.113.4 2.520.41 29.34.3** 2.460.70 30.09.0 73.517.6 1.020.09** 5.10.11** 114.416.8* 33.210.7** 15.51.5
*Statistically significantly different from controls (p<0.05).
**Statistically significantly different from controls (p<0.01).
AT, anaerobic threshold; BF, breathing frequency; HR, heart rate; MBWT, modified Bruce treadmill walking test; MI, myocardial infarction; RER, respiratory exchange ratio; RPE; rating of
perceived exertion.
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However, percentage LBM was inversely associated
with BF (F(2,5)=6.71, p<0.01) and positively associated
with VO2 (L/min) (F(2,5)=8.88, p=0.003). Increased
body mass (kg) also resulted in enhanced production
of VCO2 (L/min) (F(2,5)=18.43, p<0.01). Other meas-
ures of body composition did not reach the level of
statistical significance.
Secondary analysis performed using GLM with LBM
as a covariate showed LBM was not sufficiently strong to
influence the significant increased BF in the post-MIs;
thus, indicating LBM alone was not the only contrib-
uting factor. Correlations also show stronger
relationships in relation to the increased BF during the
MBWT than LBM (R=-0.312, p=0.001), such as RER
(R=0.523, p=0.001), RPE (R=0.430, p=0.001), VCO2
(L/min) (R=0.431, p=0.001), VCO2 (mL/kg/min)
(R=0.441, p=0.001) and gross (kcal/min) (R=0.523,
p=0.001).
Perceived exertion
Post-MIs were found to reach the subjective point of
‘slightly breathless/slightly sweaty’ at a significantly
lower VO2 (mL/kg/min) compared with the controls
(post-MI, 11.11.6 vs controls, to 12.62.2 VO2 mL/kg/
min, T=2.23, p=0.033). This corresponded to 13 on
the Borg 6–20 RPE scale for the post-MIs and 13.7 for
the non-cardiac controls. However, calculations revealed
that both groups subjectively reached the point of
‘slightly breathless/slightly sweaty’ at around 43% of
their respective AT (see above for other RPE results).
DISCUSSION
Any misrepresentation in the results of the modified
Bruce protocol1 has the potential for incorrect evalua-
tion of a cardiac patient’s health status, as well as
unsafe or ineffective exercise prescription. It is there-
fore important that the value, indices or equation
employed to establish the point of functional capacity
and/or ischaemia is as precise as possible. The findings
of this study however indicate that the ascribed MET
values appear to misrepresent the potential metabolic
load of exercise for post-MIs during graded exercise.
Although post-MI participants were found to produce
significantly higher RER values throughout the MBWT,
the post-MIs and non-cardiac controls showed no
significant differences in VO2, VCO2, METs, RPE or
HR. Yet, the anaerobic component per MET (%AT/
MET) was significantly greater for the post-MI group.
Comparable findings have been found from three
other studies, which also compared male phase-IV
post-MI patients with non-cardiac controls during
graded exercise.12 23 24 All these studies found no
statistically significant difference in VO2 (mL/kg/min)
or derived METs between groups, but upon secondary
analysis did show significantly greater %AT/MET from
all post-MI groups, a difference that increased with
exercise intensity.24 This enhanced %AT/MET of the
post-MIs was found irrespective of study design, mode
of exercise or variations between studies in any
resulting VO2 parameters and/or subjective markers of
exercise intensity, which are discussed in more detail
in a twin paper.24 These findings strongly indicate that
the evaluation of a cardiac patient’s VO2 values or
derived MET values alone is insufficient in revealing
the ‘true’ exercise intensity at which a cardiac patient is
working. This is especially interesting as the cardiac
patients in these studies were all of phase-IV CR level;
patients who exercise regularly out in the community
and arguably some of the physically fittest.
Because those with more severe forms of cardiac
disease are known to work more anaerobically during
exercise,25 it is likely that those with more severe
cardiac disease will work at an even greater %AT/MET
than shown from the post-MIs of these studies.
VO2 (mL/kg/min)–work relationship
Analysis found no significant difference in mean VO2
values or derived METs between groups, other than
post-MI participants showing significantly lower METs
than those ascribed for stage 5. Conversely, a study by
Woolf-May and Ferrett11 found the linear VO2–walking
speed relationship to be significantly greater from a
group of post-MI men (n=31, age 63.26.5 years)
compared with a group of non-cardiac controls (n=19,
age 64.67.5 years) during the 10 m flat shuttle
walking test.26 The findings revealed walking at 4 mph
Table 5 Ascribed and achieved MET values during the stages of the MBWT
Stage Ascribed METs1
Non-cardiac controls’ METs
Mean±SD
Post-MI patients’ METs
Mean±SD
1 1.7 2.70.1 3.00.5
2 2.9 3.50.5 3.70.5
3 4.7 4.70.7 4.60.7
4 7.1 6.60.5 6.60.7
5 10.2 9.50.9 8.51.1*
*Statistically significantly different from ascribed MET values at p<0.01.
MBWT, modified Bruce treadmill walking test; MET, metabolic equivalent; MI, myocardial infarction.
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was around 6 METs for the non-cardiac controls but
nearer 8 METs for the post-MI group. Similarly, a
more recent paper from Buckley et al27 observed the
VO2–walking speed relationship was up to 30% greater
at the higher stages of a 10 m shuttle walking test from
n=32CR patients in comparison to n=30 age-matched
controls. Buckley et al27 found the VO2 (mL/kg/min)
linear regression models’ underestimated values for
cardiac participants, showing the VO2 response to be
curvilinear, with the area under the curve being
greater in the cardiac group (cardiac=42386 vs
control=31652mL/kg/min/km/h, p<0.001). This
therefore brings into question the use of linear VO2
(mL/kg/min) based equations in determining exercise
intensity in cardiac groups.
VCO2 production and body composition
Regression analysis showed the point of RER=1.0 (AT)
to be reached sooner at a lower VO2 of 25.6 for post-
MI participants when compared with 31.1 VO2 (mL/kg/
min) for the non-cardiac controls. Similar findings
have also been reported between phase-IV cardiac
patients compared with non-cardiac controls in studies
involving shuttle walking,23 treadmill walking12 and
cycle ergometry.24 Although the groups in this study
were well matched for age, physical activity and body
mass, they did however differ in body composition
(table 2). Yet, analysis did not find body composition
to have any influence on VCO2, VO2 parameters or
METs. In fact, METs were adjusted for cardiac patients
to 2.84mL/kg/min per MET over a range of exercise
modes, results showing inconsistent outcomes. This
suggested the difference in METs between the groups
of post-MI men and their non-cardiac counterparts was
not entirely due to body composition.24 Furthermore,
although the post-MI group displayed a significantly
greater gross energy expenditure over the duration of
the MBWT than controls, it is unlikely that this was
due to differences in body composition between the
groups (table 2). Because even though the post-MI
group’s BMI was significantly greater, the controls had
significantly more LBM, and lower per cent body fat
and kilogram of body fat, with both groups showing no
significant difference in body mass. Therefore, the
controls would appear to have relatively more ‘active’
tissue with the potential for using more energy.
Secondary analysis of our data did however indicate
that body composition was a possible contributor to the
increased VCO2 production and increased BF, where
the greater the LBM the lower the BF and VCO2
production. Nonetheless, further analysis revealed
LBM was still not statistically strong enough to elimi-
nate the significant impact of VCO2 production upon
the increased BF seen in the post-MI group.
Ratings of perceived exertion
A secondary aim of the study was to determine how
subjectively the participants rated their exercise inten-
sity in relation to the physiological markers and METs.
Our findings revealed that during the MBWT, the unva-
lidated subjective point of ‘slightly breathless, slightly
sweaty’ was achieved around 43% of AT for both groups,
yet at this point post-MIs reported a lower RPE of 13.0,
while the controls reported 13.7. A study by Scherr
et al
28 comparing graded exercise RPE values of coro-
nary artery disease (CAD) patients (n=146, mean age
66 years, BMI 26.7 and 2hours of weekly exercise) with
non-cardiac participants (n=2560), using the Borg 6–20
Figure 1 %AT–MET relationship during the MBWT for post-MI group versus non-cardiac controls. AT, anaerobic threshold;
MBWT, modified Bruce treadmill walking test; MET, metabolic eqivalent; MI, myocardial infarction.
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scale,19 showed CAD patients significantly under-rated
RPE at blood lactate values of 3.0 and 4.0mmoL/L
compared with non-cardiac controls (3mmoL/L: CAD,
12.01.7 vs total cohort, 13.01.9RPE, p<0.001;
4mmoL/L: CAD, 14.01.7 vs total cohort,
14.21.9RPE, p<0.01). Forti29 also found male CAD
patients (mean age 56 years, n=10, taking beta-blockers,
and n=10, not taking beta-blockers) to report signifi-
cantly lower RPE values (Borg CR 10 scale)30 during
cycle ergometry compared with n=10 non-
cardiac patients (RPE: 4.9, 5.9 and 6.5, respectively).
Additionally, Joo et al31 reported there is to be substan-
tial intersubjective variability from n=11 cardiac
patients (of mix condition and gender taking beta-
blockers) during overground walking at RPE 11–1319
from the 6–20 scale in relation to predetermined %VO2
reserve (VO2R). Nine per cent of cardiac patients walked
at <40%, 9%<40%–60%and 82%<60% VO2R.
Although cardio-selective beta-blockers seem not to
affect RPE responses compared with non-cardio-selec-
tive beta-blockers,32 it has therefore been postulated
that different cardio-selectivity beta-blockers may be
influential on reporting RPE values. Notwithstanding,
secondary analysis of the MET–RPE relationship during
the MBWT of this study found no significant differences
between the groups in RPE values.
CONCLUSION
Aligned with other studies, the findings of this study
clearly showed post-MI men worked more anaerobi-
cally per MET than non-cardiac men during graded
exercise, indicating current METs to underestimate the
metabolic load of the post-MI patients. Therefore,
current METs would appear unsuitable for deter-
mining the true exercise intensity of cardiac patients
during the MBWT.
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